The Journal of Thoracic and Cardiovascular Surgery
Volume 156, Issue 3, September 2018, Pages 1067-1068
Editorial CommentaryTranscatheter therapies have not forgotten the tricuspid valve
Under an Elsevier user license
open archive
Cited by (0)
Disclosures: T.R.: Consultant: Medtronic. Intellectual property: co-inventor on patents, assigned to the National Institutes of Health, for transcatheter devices to treat TR. V.H.T.: Advisor/Research: Edwards Lifesciences, Abbott Vascular, Claret Medical, Boston Scientific, Gore Vascular, and JenaValve.
© 2018 by The American Association for Thoracic Surgery